Psychiatric disorders and adherence to antiretroviral therapy among a population of HIV-infected adults in Nigeria
- 18 September 2015
- journal article
- research article
- Published by SAGE Publications in International Journal of STD & AIDS
- Vol. 27 (11), 938-949
- https://doi.org/10.1177/0956462415600582
Abstract
Summary Psychiatric disorders are common among people living with HIV in Nigeria. Adherence is necessary to optimise the outcome of antiretroviral therapy. In this study, we aimed to identify associations between antiretroviral adherence, measured by one-week and one-month self-reported missed doses, and psychiatric illness in a cohort previously assessed for psychiatric disorders using the Composite International Diagnostic Interview. The study participants comprised 151 adults with major depression, anxiety or suicidal symptoms, and 302 matched-control participants. Two controls were randomly selected for each case within the same gender and education level. We compared participants with psychiatric disorders (WPDs) and no psychiatric disorders (NPDs) on selected demographic and clinical variables, in addition to adherence. Participants with one or more missed doses in the preceding month had twice the odds of having a major depressive episode as those with no missed doses during this period (OR 2.22, 95% CI 1.03, 4.79). This association remained significant after adjusting for selected risk factors. There was no statistically significant difference between WPD and NPD groups on either one-week or one-month adherence, or on age, marital status, occupational class, HIV viral load at enrolment or current CD4 cell count. Among Nigerian adults with HIV, suboptimal antiretroviral adherence is associated with, and could be a sign of, depression. Routine self-report adherence assessments may potentially be utilised in identifying individuals at risk among this population.Keywords
This publication has 75 references indexed in Scilit:
- The Impact of DSM-IV Mental Disorders on Adherence to Combination Antiretroviral Therapy Among Adult Persons Living with HIV/AIDS: A Systematic ReviewAIDS and Behavior, 2012
- Intracerebroventricular administration of HIV-1 Tat induces brain cytokine and indoleamine 2,3-dioxygenase expression: A possible mechanism for AIDS comorbid depressionBrain, Behavior, and Immunity, 2011
- A Closer Look at Depression and Its Relationship to HIV Antiretroviral AdherenceAnnals of Behavioral Medicine, 2011
- Contributions of HIV infection in the hypothalamus and substance abuse/use to HPT dysregulationPsychoneuroendocrinology, 2011
- Chronic pain conditions and depression in the Ibadan Study of AgeingInternational Psychogeriatrics, 2011
- Two-year prospective study of major depressive disorder in HIV-infected menJournal of Affective Disorders, 2008
- From inflammation to sickness and depression: when the immune system subjugates the brainNature Reviews Neuroscience, 2008
- Functional Disability in Elderly Nigerians: Results from the Ibadan Study of AgingJournal of the American Geriatrics Society, 2006
- Adherence to antiretroviral therapy and its impact on clinical outcome in HIV-infected patientsJournal of The Royal Society Interface, 2005
- Prevalence, Severity, and Unmet Need for Treatment of Mental Disorders in the World Health Organization World Mental Health SurveysJAMA, 2004